Chimeron Bio

Philadelphia, United States

Chimeron Bio develops agents for personalized cancer gene therapy.

$12.8M raised

Mar 2025

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Chimeron Bio raised?

Chimeron Bio has raised $12.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.

Who are Chimeron Bio's investors?

Chimeron Bio's investors include Dreavent Capital.

Where is Chimeron Bio headquartered?

Chimeron Bio is headquartered in Philadelphia, United States.

What does Chimeron Bio do?

Chimeron Bio develops agents for personalized cancer gene therapy.

What stage is Chimeron Bio at?

Chimeron Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 14, 2025.

MLA

"Chimeron Bio — Funding & Investors." VCBacked, March 14, 2025, https://www.vcbacked.co/company/chimeron-bio. Accessed July 2, 2026.

APA

VCBacked. (2025). Chimeron Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/chimeron-bio

Wikipedia (cite web)

{{cite web |title=Chimeron Bio — Funding & Investors |url=https://www.vcbacked.co/company/chimeron-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 14, 2025.